Clinical Scorecard: Association of Frailty with Mortality Rates in Chronic Subdural Hematoma Patients
At a Glance
Category
Detail
Condition
Chronic Subdural Hematoma (CSDH)
Key Mechanisms
Frailty syndrome involving deterioration of neurological, musculoskeletal, cardiovascular, metabolic, and immunological systems leading to vulnerability and increased mortality
Target Population
Adults aged 18 years and older with CSDH, predominantly elderly patients
Care Setting
Neurosurgical referral centers and hospitals with neurosurgical facilities
Key Highlights
CSDH has a 12-month mortality rate of 15–20%, comparable to certain cancers.
Frailty is a significant factor associated with increased mortality in CSDH patients.
Frailty can be measured using six clinical items including cognitive status, falls, independence, self-care ability, psychotropic drug use, and polypharmacy.
Guideline-Based Recommendations
Diagnosis
Diagnose CSDH via CT scan showing hypodense hematoma with limited hyperdense components.
Assess frailty using six-item criteria: cognitive problems, frequent falls, independence status, self-care ability (mRS ≥4), benzodiazepine/psychotropic drug use, and total medication count.
Management
Consider neurosurgical intervention based on clinical presentation and imaging.
Address frailty components to potentially reduce mortality risk.
Monitoring & Follow-up
Monitor functional status using Markwalder grading scale and modified Rankin scale.
Track comorbidities using Charlson Comorbidity Index.
Follow survival outcomes via national mortality data.
Risks
Increased mortality associated with frailty and comorbidities in CSDH patients.
Polypharmacy and use of psychotropic medications may contribute to adverse outcomes.
Patient & Prescribing Data
CSDH patients, primarily elderly with multiple comorbidities and frailty features
Use of benzodiazepines or psychotropic drugs is a frailty marker; careful medication review is advised to reduce risk.
Clinical Best Practices
Evaluate frailty systematically at diagnosis to identify high-risk patients.
Incorporate frailty assessment into surgical decision-making and postoperative care planning.
Implement interventions targeting frailty components to improve survival outcomes.
Use matched control data to contextualize mortality risk in CSDH patients.
by Jurre Blaauw, Bram Jacobs, Heleen M. den Hertog, Niels A. van der Gaag, Korné Jellema, Ruben Dammers, Kuan H. Kho, Rob J. M. Groen, Joukje van der Naalt, Hester F. Lingsma
Epilepsy remains a life-altering condition, particularly due to the unpredictable nature of seizures and their cumulative impact on cognition, independence and quality of life.
